2024 annual financial data
Dyne Therapeutics, Inc. 2024 Operating margin
Dyne Therapeutics, Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -343,886,000 USD and net income was -317,418,000 USD.
Operating cash flow was -292,369,000 USD.
Get free Dyne Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -343,886,000 USD
- Net income
- -317,418,000 USD
- Operating cash flow
- -292,369,000 USD